Application progress of perioperative intravenous lidocaine injection in thoracic surgery
- VernacularTitle:围术期静脉输注利多卡因在胸科手术中的应用进展
- Author:
Wei SHI
1
;
Yifeng REN
2
;
YU Hai
1
Author Information
1. Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China
2. Department of Anesthesiology, First Affiliated Hospital of Henan University, Kaifeng, 475001, Henan, P.R.China
- Publication Type:Journal Article
- Keywords:
Perioperation;
intravenous injection;
lidocaine;
thoracic surgery
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2020;27(05):579-583
- CountryChina
- Language:Chinese
-
Abstract:
Lidocaine is an amide local anaesthetic. In recent years, clinical evidence shows that perioperative intravenous lidocaine injection plays an active role in anti-inflammation, analgesia, anti-tumor and organ protection. Postoperative pain is severe in patients after thoracic surgery, and the incidence of pulmonary complications and cognitive impairment is high. These adverse reactions and complications are closely related to the inflammatory reaction after thoracic surgery. Intravenous infusion of lidocaine may have some effects on alleviating these adverse reactions and complications. Thus, this article reviews the current status of intravenous lidocaine injection in thoracic surgery and explores the related mechanisms to optimize the management of anaesthesia during the perioperative period of thoracic surgery.
